Synthesis and in vitro anticancer and anti-HIV evaluation of new 2-mercaptobenzenesulfonamides

Farmaco

Volumn 56, Issue 8, 2001, Pages 571-577

  Pomarnacka, Elbieta ^a   Kornicka, Anita ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

2 Mercaptobenzenesulfonamides; Anticancer and anti HIV activities; Synthesis

Indexed keywords

1 BENZYL 2 (4 CHLORO 2 MERCAPTO 5 METHYLBENZENESULFONYLIMINO)IMIDAZOLIDINE; 1,3 DIBENZYL 2 (4 CHLORO 2 MERCAPTO 5 METHYLBENZENESULFONYLIMINO)IMIDAZOLIDINE; 2 MERCAPTOBENZENESULFONAMIDE DERIVATIVE; 4 CHLORO 2 MERCAPTO 5 METHYL N (4 PHENYL 3,4 DIHYDROQUINAZOLIN 2 YL)BENZENESULFONAMIDE DERIVATIVE; 4 CHLORO 2 MERCAPTO 5 METHYL N (PYRIDO[3,2 D]IMIDAZOL 2 YL)BENZENESULFONAMIDE; 6 CHLORO 3 METHYLTHIO 1,4,2 BENZODITHIAZINE 1,1 DIOXIDE DERIVATIVE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BIS[2 (6 CHLORO 4 PHENYL 3,4 DIHYDROQUINAZOLIN 2 YL)AMINOSULFONYL 5 CHLORO 4 (PHENYLCARBOMOYL)PHENYL]DISULFIDE DERIVATIVE; BIS[2 (PYRIDO[3,2 D]IMIDAZOL 2 YL)AMINOSULFONYL 5 CHLORO 4 (PHENYLCARBOMOYL)PHENYL]DISULFIDE DERIVATIVE; N (PYRIDO[3,2 D]IMIDAZOL 2 YL) 2 MERCAPTOBENZENESULFONAMIDE; OXIDE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG SCREENING; DRUG SENSITIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; KIDNEY CARCINOMA; LEUKEMIA; LUNG NON SMALL CELL CANCER; MELANOMA; NONHUMAN; OVARY CARCINOMA; OXIDATION; PROSTATE CARCINOMA; REACTION ANALYSIS; VIRUS INFECTION;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; FEMALE; HIV-1; HUMANS; LETHAL DOSE 50; MALE; STRUCTURE-ACTIVITY RELATIONSHIP; SULFHYDRYL COMPOUNDS; SULFONAMIDES; TUMOR CELLS, CULTURED;

EID: 0035424098     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(01)01095-3     Document Type: Article

References (20)

1. Discovery of potent, achiral matrix metalloproteinase inhibitors
2. Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle
3. Design and synthesis of piperazine-based matrix metalloproteinase inhibitors
4. Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors
5. Cyclin-dependent kinase inhibitors: Useful of targets in cell cycle regulation
6. Protease inhibitors: Current status and future prospects
7. Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers
8. Design and discovery of HIV-1 integrase inhibitors
9. 2-Mercaptobenzenesulfonamides as novel inhibitors of human immunodeficiency virus type 1 integrase and replication
10. Thiazolothiazepine inhibitors of HIV-1 integrase
11. 2-Mercapto-N-(azolyl)benzenesulfonamides. V. Syntheses, anti-HIV and anticancer activity of some 4-chloro-2-mercapto-5-methyl-N-(1,2,4-triazolo[4,3-a]pyrid-3-yl) benzenesulfonamides
12. 2-Mercapto-N-(azolyl)benzenesulfonamides. VI. Synthesis and anti-HIV activity of some new 2-mercapto-N-(1,2,4-triazol-3-yl)benzenesulfonamide derivatives containing the 1,2,4-triazole moiety fused with a variety of heteroaromatic rings
13. Synthesis, anti-HIV and anticancer activities of new 4-(2-mercaptobenzenesulfonyl)perhydro-1,2,4-triazin-3-ones
14. Syntheses of some 2-hydroxy-1-[(4-chloro-2-mercaptophenyl)sulfonyl]imidazole derivatives with potential anticancer activity
15. Synthesis of some 3-mercapto-1,1-dioxo-1,4,2-benzodithiazine derivatives
16. 1-3-methylothio-1,1-dioxo-1,4,2-benzodithiazino-7-carboxylic acids
17. Investigation of prototropic equilibria by carbon-13 relaxation time analysis
18. 1,3-Unsubstituted 1,2,3,4-tetra-hydroquinazolines from 1,3-diamines
19. New soluble-formazan assay for HIV-1 cytophatic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity
20. Status of the NCI preclinical antitumor drug discovery screen